EcoDrugPlus

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSCPOG00000032690
Gene Symbol: ALOX5AP
2 Cross references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSCPOG00000034144
Gene Symbol: AVPR1A
4 Cross references
268 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSCPOG00000036821
Gene Symbol: AVPR1B
2 Cross references
135 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSCPOG00000012697
Gene Symbol: AVPR2
2 Cross references
251 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSCPOG00000005481
Gene Symbol: AHR
2 Cross references
155 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSCPOG00000003286
Gene Symbol: AURKB
2 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSCPOG00000012661
Gene Symbol: AURKC
2 Cross references
99 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSCPOG00000012754
Gene Symbol: BACE1
4 Cross references
220 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSCPOG00000015420
Gene Symbol: BDKRB2
4 Cross references
362 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSCPOG00000004998
Gene Symbol: BCHE
4 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSCPOG00000001012
Gene Symbol: CALCRL
4 Cross references
149 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSCPOG00000013000
Gene Symbol: CASR
2 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).